GALERA THERAPEUTICS INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRTX and buy or sell other stocks, ETFs, and their options commission-free!About GRTX
Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer.
CEOJohn Mel Sorensen
CEOJohn Mel Sorensen
Employees3
Employees3
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2009
Founded2009
Employees3
Employees3
GRTX Key Statistics
Market cap1.80M
Market cap1.80M
Price-Earnings ratio-0.18
Price-Earnings ratio-0.18
Dividend yield—
Dividend yield—
Average volume11.54K
Average volume11.54K
High today$0.0249
High today$0.0249
Low today$0.0227
Low today$0.0227
Open price$0.0227
Open price$0.0227
Volume986.00
Volume986.00
52 Week high$0.051
52 Week high$0.051
52 Week low$0.0151
52 Week low$0.0151
Stock Snapshot
GALERA THERAPEUTICS INC(GRTX) stock is priced at $0.02, giving the company a market capitalization of 1.8M. It carries a P/E multiple of -0.18.
On 2026-01-23, GALERA THERAPEUTICS INC(GRTX) stock traded between a low of $0.02 and a high of $0.02. Shares are currently priced at $0.02, which is +4.8% above the low and -4.4% below the high.
GALERA THERAPEUTICS INC(GRTX) shares are trading with a volume of 986, against a daily average of 11.54K.
In the last year, GALERA THERAPEUTICS INC(GRTX) shares hit a 52-week high of $0.05 and a 52-week low of $0.02.
In the last year, GALERA THERAPEUTICS INC(GRTX) shares hit a 52-week high of $0.05 and a 52-week low of $0.02.
People also own
Based on the portfolios of people who own GRTX. This list is generated using Robinhood data, and it’s not a recommendation.